Cargando…

Surveillance for Patients with Oral Squamous Cell Carcinoma after Complete Surgical Resection as Primary Treatment: A Single-Center Retrospective Cohort Study

SIMPLE SUMMARY: Surveillance methods for oral squamous cell carcinoma (OSCC) patients may be chosen by considering the risk of recurrence. We performed a retrospective cohort study in 324 OSCC patients after complete surgical resection as the primary treatment from 2007 to 2020 at our hospital. Rega...

Descripción completa

Detalles Bibliográficos
Autores principales: Fukumoto, Chonji, Oshima, Ryo, Sawatani, Yuta, Shiraishi, Ryo, Hyodo, Toshiki, Kamimura, Ryouta, Hasegawa, Tomonori, Komiyama, Yuske, Izumi, Sayaka, Fujita, Atsushi, Wakui, Takahiro, Kawamata, Hitoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616227/
https://www.ncbi.nlm.nih.gov/pubmed/34830994
http://dx.doi.org/10.3390/cancers13225843
Descripción
Sumario:SIMPLE SUMMARY: Surveillance methods for oral squamous cell carcinoma (OSCC) patients may be chosen by considering the risk of recurrence. We performed a retrospective cohort study in 324 OSCC patients after complete surgical resection as the primary treatment from 2007 to 2020 at our hospital. Regarding the time to occurrence of postsurgical events, we found that half of cases of local recurrence, cervical lymph node, and distant metastasis occurred within 200 days, and 75% of all these events occurred within 400 days. However, the mean time for second primary cancer was 1589 days. The postsurgical events were detected by imaging examinations earlier than they were by visual examination and palpation. It is desirable to perform FDG-PET/CT within 3–6 months and at 1 year after surgery and to consider CECT as an option in between FDG-PET/CT, while continuing history and physical examinations for about 5 years based on an individual risk assessment. ABSTRACT: Background: The surveillance methods oral squamous cell carcinoma (OSCC) patients may be chosen by considering the risk for recurrence, and it is important to establish appropriate methods during the period in which latent/dormant cancer cells become more apparent. To investigate the appropriate surveillance of patients with OSCC based on the individual risk for recurrence and/or metastasis, we performed a retrospective cohort study after the complete surgical resection of OSCC as the primary treatment. Methods: The study was performed in 324 patients with OSCC who had been primarily treated with surgery from 2007 to 2020 at our hospital. We investigated the period, timing, and methods (visual examination, palpation and imaging using FDG-PET/CT or CECT) for surveillance in each case that comprised postsurgical treatment. Results: Regarding the time to occurrence of postsurgical events, we found that half of cases of local recurrence, cervical lymph node metastasis, and distant metastasis occurred within 200 days, and 75% of all of these events occurred within 400 days. However, the mean time for second primary cancer was 1589 days. The postsurgical events were detected earlier by imaging examinations than they were by visual examination and palpation. Conclusions: For the surveillance of patients with OSCC after primary surgery, it is desirable to perform FDG-PET/CT within 3–6 months and at 1 year after surgery and to consider CECT as an option in between FDG-PET/CT, while continuing history and physical examinations for about 5 years based on individual risk assessment.